We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Cabergoline 1mg tablets (Teva, UK)
Section 19A approved medicine
Cabergoline 1mg tablets (Teva, UK)
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Current
Medicines in short supply/unavailable
CABASER Cabergoline 1mg tablet bottle - ARTG 57360
CABASER Cabergoline 2mg tablet bottle - ARTG 57367
CABASER Cabergoline 2mg tablet bottle - ARTG 57367
Indication(s)
For the management of the signs and symptoms of Parkinson’s Disease. Treatment should be initiated under specialist supervision. The benefit of continued treatment should be regularly reassessed taking into account the risk of fibrotic reactions and valvulopathy.
Images
